Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination against papillomavirus.

M S Campo1

  • 1Beatson Institute for Cancer Research, Bearsden, Glasgow, UK.

Cancer Cells (Cold Spring Harbor, N.Y. : 1989)
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

Virology·2010
Same author

Bovine papillomavirus type 1 E2 and E7 proteins down-regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts.

Virus research·2010
Same author

Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland.

The British journal of dermatology·2009
Same author

Papillomavirus and disease in humans and animals.

Veterinary and comparative oncology·2009
Same author

Quercetin induces structural chromosomal aberrations and uncommon rearrangements in bovine cells transformed by the E7 protein of bovine papillomavirus type 4.

Veterinary and comparative oncology·2009
Same author

Bovine papillomavirus type 1 DNA and E5 oncoprotein expression in water buffalo fibropapillomas.

Veterinary pathology·2009

Papillomaviruses cause benign skin tumors in humans and animals. Successful animal vaccines offer hope for treating human papillomavirus infections and preventing associated cancers.

Area of Science:

  • Veterinary medicine
  • Oncology
  • Immunology

Background:

  • Papillomaviruses cause benign epidermal tumors like warts and papillomas in humans and animals.
  • These lesions can persist and, with additional factors, progress to cancer.
  • Effective vaccines are needed for treating persistent warts and preventing malignant transformation.

Purpose of the Study:

  • To explore the potential of papillomavirus vaccines for human applications.
  • To highlight the implications of successful animal vaccination for human papillomavirus (HPV)-associated conditions.

Main Methods:

  • Review of studies on papillomavirus vaccines in cattle.
  • Analysis of vaccine efficacy in prophylaxis and tumor rejection.

Main Results:

Related Experiment Videos

  • Successful prophylaxis and tumor rejection achieved in cattle using conventional and genetically engineered vaccines.
  • Demonstrated efficacy of vaccines against epidermal and alimentary canal tumors in animals.

Conclusions:

  • Animal vaccination success provides a model for human papillomavirus (HPV) management.
  • Vaccines hold promise for treating recalcitrant warts and preventing HPV-driven cancers like cervical carcinoma and laryngeal papillomas.